Overview


According to FutureWise analysis the market for biosensors in 2023 is US$ 29.59 billion, and is expected to reach US$ 53.64 billion by 2031 at a CAGR of 7.70%.

The abbreviation "biosensor" stands for "biological sensor. The instrument consists of a transducer and a biological component, which could be an enzyme, an antibody, or a nucleic acid. The transducer converts the biological response from the bioelement's interaction with the analyte under investigation into an electrical signal. Depending on their specific use, biosensors are also referred to as immunosensors, optrodes, resonant mirrors, chemical canaries, biochips, glucometers, and biocomputers. A biosensor is typically described as follows: "A chemical sensing device that couples a transducer with a biologically derived recognition to enable the quantitative development of some complex biochemical parameter."

The wide range of medical applications, the rise in diabetes patients, the high demand for small diagnostic tools, and the quick pace of technological advancement all contribute to the rising demand for biosensors. For a good disease prognosis and the patient's survival, early and accurate identification of the illness is essential. The demand for disposable, practical, affordable devices with quick response times has grown significantly over the past few years. Due to their capacity to achieve these requirements through a mix of interdisciplinary approaches in chemistry, nanotechnology, and medicine, these devices have advanced quickly in the medical arena. Numerous elements that have both positive and negative effects on the market's dynamics influence its growth.

FutureWise Market Research has published a report that provides an insightful analysis of biosensors market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the biosensors market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Abbott Laboratories Inc.
  • F. Hoffman-La Roche
  • Medtronic
  • Universal Biosensors
  • Siemens
  • Lifescan
  • Bayer Healthcare AG
  • Bio-Rad Laboratories, Inc.
  • Dowdupont Inc.
  • Sysmex Corporation
  • Biacore
  • Biosensors International PTE. Ltd.
  • Ercon Inc.
  • Lifesensors
  • Nova Biomedical
  • Acon Laboratories, Inc.
  • Pharmaco-Kinesis Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

The biosensors are used in medicine to distinguish between different biological components. Biosensors are also frequently employed in the healthcare sector to detect, recognize, and monitor various dangerous disorders. The market for biosensors is expanding as chronic diseases become increasingly prevalent. The World Health Organisation (WHO) reports that the prevalence of chronic diseases is steadily rising. The rising incidence of diabetes worldwide is one of the key factors boosting the growth of the biosensors market. The widespread detection of diabetes is directly aided by the biosensors' capacity to measure blood glucose levels. As a result, this factor is promoting the market for biosensors expansion and growth. Moreover, biosensors' sensitivity threshold has increased due to recent advancements in biological methods utilizing fluorescent tags on nanomaterials. Additionally, smartwatches use Photoplethysmography (PPG) biosensors to monitor a user's health as they exercise, sleep, and go about their daily activities. The PPG sensor also monitors fluctuations in blood flow and provides valuable information about the cardiovascular system. It is anticipated that the development of biosensors into user-friendly devices would offer lucrative opportunities for the leading industry players to expand this target market. However, The amount of data and lack of standards have prevented the market for biosensors from growing. To lower the time and effort needed to examine the enormous volumes of data available to institutions and governments worldwide, a user-friendly database is necessary. In order to address the statistical problems caused by the integrated analysis of high-throughput genomic and biomedical research data, integration approaches must be improved. However, it is projected that the high cost of such activities' development will restrict the growth of the biosensors market.

By Type

  • Sensor Patch
  • Embedded Device

By Product

  • Wearable Biosensors
    • Wristwear
    • Eyewear
    • Footwear
    • Neckwear
    • Bodywear
    • Others
  • Nonwearable Biosensors

By Technology

  • Electrochemical Biosensors
    • Amperometric Sensors
      • Blood Glucose Sensors
    • Potentiometric Sensors
      • Immunosensors
    • Conductometric Sensors
  • Optical Biosensors
    • SPR
    • Colorimetric Biosensors
    • Fluorescence Biosensors
  • Piezoelectric Biosensors
    • Acoustic Biosensors
    • Microcantilever Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors
  • Others

By Application

  • POC
    • Glucose Monitoring
    • Cardiac Marker
    • Infectious Disease Detection
    • Coagulation Monitoring
    • Pregnancy Testing
    • Blood Gas And Electrolyte Detection
    • Tumor Or Cancer Marker
    • Urinalysis Testing
    • Cholesterol Testing
  • Home Diagnostics
    • Glucose Monitoring
    • Pregnancy Testing
    • Cholesterol Testing
  • Research Lab
  • Biodefense
  • Environmental Monitoring
  • Food And Beverages

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. APAC registered the highest share in the market in 2022. The development of cutting-edge healthcare infrastructure in countries like China and India is anticipated to fuel market revenue growth, among other factors influencing the growth of the Asia Pacific market. Examples include recently added raw materials and vaccines in China's National Encouraged Lists, which demonstrate how China is enticing investors to build more advanced healthcare facilities and opening up new investment opportunities for foreign companies in the region.

Additionally based on type; Embedded device holds the highest share followed by based on Product; wearable biosensors hold the highest CAGR. The advantages of wearable biosensors are leading to an increase in hospitals employing these products to monitor patient health. This opens the possibility of changing standard medical diagnostic concepts and health monitoring. Wearable biosensors improve self-care at home and speed up the diagnosis. In addition to being handy and pleasant, these devices provide real-time information on a patient's health state and do away with the necessity for uncomfortable fingersticks. As a result, real-time data makes it possible to make better clinical judgments and diagnoses in less time, which can lead to better and more accurate health outcomes and more effective use of healthcare systems.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Biosensors Market By Type, By Product, By Technology, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Biosensors Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Biosensors Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Biosensors Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Biosensors Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Sensor Patch
        2. Embedded Device

  • 8.   Biosensors Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Wearable Biosensors
         1.1. Wristwear
         1.2. Eyewear
         1.3. Footwear
         1.4. Neckwear
         1.5. Bodywear
         1.6. Others
        2. Nonwearable Biosensors

  • 9.   Biosensors Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Electrochemical Biosensors
         1.1. Amperometric Sensors
          1.1.1. Blood Glucose Sensors
         1.2. Potentiometric Sensors
          1.2.1. Immunosensors
         1.3. Conductometric Sensors
        2. Optical Biosensors
         2.1. SPR
         2.2. Colorimetric Biosensors
         2.3. Fluorescence Biosensors
        3. Piezoelectric Biosensors
         3.1. Acoustic Biosensors
         3.2. Microcantilever Biosensors
        4. Thermal Biosensors
        5. Nanomechanical Biosensors
        6. Others

  • 10.   Biosensors Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. POC
         1.1. Glucose Monitoring
         1.2. Cardiac Marker
         1.3. Infectious Disease Detection
         1.4. Coagulation Monitoring
         1.5. Pregnancy Testing
         1.6. Blood Gas And Electrolyte Detection
         1.7. Tumor Or Cancer Marker
         1.8. Urinalysis Testing
         1.9. Cholesterol Testing
        2. Home Diagnostics
         2.1. Glucose Monitoring
         2.2. Pregnancy Testing
         2.3. Cholesterol Testing
        3. Research Lab
        4. Biodefense
        5. Environmental Monitoring
        6. Food And Beverages

  • 11.   North America Biosensors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Biosensors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Biosensors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Biosensors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. F. Hoffman-La Roche
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Universal Biosensors
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Siemens
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Lifescan
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bayer Healthcare AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bio-Rad Laboratories, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Dowdupont Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Sysmex Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Biacore
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Biosensors International Pte. Ltd.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Ercon Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Lifesensors
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Nova Biomedical
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Acon Laboratories, Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Pharmaco-Kinesis Corporation
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients